tiprankstipranks
Trending News
More News >
Capricor Therapeutics (CAPR)
NASDAQ:CAPR

Capricor Therapeutics (CAPR) Revenue

Compare
931 Followers

Capricor Therapeutics Revenue

Capricor Therapeutics had a revenue of 11.13M in the quarter ending Dec 31, 2024, with 392.14%. This bring the company's revenue in the last twelve months to 22.27M, Increased -4.12%. In the fiscal year ending Dec 31, 2024, Capricor Therapeutics had annual revenue of 22.27M with -11.55% growth.
Revenue (ttm)
22.27M
Revenue Growth
-11.55%
P/S Ratio
24.32
Revenue/Employee
$139,190
Employees
160
Market Cap
$541.73M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 202422.27M-2.91M-11.55%
Dec 31, 202325.18M22.63M+887.79%
Dec 31, 20222.55M2.30M+940.81%
Dec 31, 2021244.90K-65.35K-21.06%
Dec 31, 2020310.25K-694.78K-69.13%
Dec 31, 20191.01M-666.33K-39.87%
Dec 31, 20181.67M304.17K+22.25%
Dec 31, 20171.37M-1.82M-57.14%
Dec 31, 20163.19M-585.93K-15.52%
Dec 31, 20153.78M-1.01M-21.11%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis